Our aim was identify brain areas involved in the premonitory phase of migraine using functional neuroimaging. To this end, we performed positron emission tomography scans with H 2 15 O to measure cerebral blood flow as a marker of neuronal activity. We conducted positron emission tomography scans at baseline, in the premonitory phase without pain and during migraine headache in eight patients. We used glyceryl trinitrate (nitroglycerin) to trigger premonitory symptoms and migraine headache in patients with episodic migraine without aura who habitually experienced premonitory symptoms during spontaneous attacks. The main outcome was comparing the first premonitory scans in all patients to baseline scans in all patients. We found activations in the posterolateral hypothalamus, midbrain tegmental area, periaqueductal grey, dorsal pons and various cortical areas including occipital, temporal and prefrontal cortex. Brain activations, in particular of the hypothalamus, seen in the premonitory phase of glyceryl trinitrate-triggered migraine attacks can explain many of the premonitory symptoms and may provide some insight into why migraine is commonly activated by a change in homeostasis.
Introduction
Migraine is among the most disabling neurological problems worldwide (Murray et al., 2012) and highly costly (Stewart et al., 2003; Olesen et al., 2012) . Functional neuroimaging studies investigating the headache phase of spontaneous (Weiller et al., 1995; Afridi et al., 2005a) and nitroglycerin-induced (Bahra et al., 2001; Afridi et al., 2005b) migraine have consistently shown dorsal pontine activation, which persists after acute migraine treatment with sumatriptan. There have been no such studies in the premonitory phase that represents the earliest clinical manifestations of the attack and thus offers unique insights into migraine pathophysiology.
Many migraine patients experience premonitory symptoms that begin up to 3 days before headache and can be highly predictive of a migraine headache (Giffin et al., 2003) . In a prospective electronic diary study, for 82% of selected patients, premonitory symptoms were followed by a migraine headache within 72 h more than 50% of the time (Giffin et al., 2003) . Tiredness, neck stiffness and difficulty in concentration were the most common symptoms. Yawning, emotional changes and difficulties in reading and writing were the most predictive for a migraine headache. Electrophysiological studies also, have consistently shown lack of habituation of cortical responses to various stimuli that increases progressively in the period before headache, and normalizes with headache, consistent with the notion that the premonitory phase is likely to entail events key to migraine generation (Schoenen et al., 2003) .
Remarkably as well as triggering migraine attacks phenotypically indistinct from other attacks, nitroglycerin can trigger the premonitory symptoms again with all the characteristics of a patient's routine symptoms (Afridi et al., 2004) . Triggering of attacks was first well characterized by Iversen et al. (1989) , and has formed the basis of novel therapeutic approaches (Lassen et al., 1997) , and pathophysiological understanding of the disorder (Olesen et al., 1995) . Importantly, aura symptoms are not commonly provoked by nitroglycerin and patients with migraine with aura get migraine headache without aura on exposure to nitroglycerin (Christiansen et al., 1999; Afridi et al., 2004) . Here, we set out to investigate the premonitory phase of nitroglycerin-induced migraine using PET scanning.
Patients and methods
We conducted telephone interviews, after advertisements in local media, to select patients who met the inclusion criteria: age 18-65 years, migraine without aura (Headache Classification Committee of The International Headache Society, 2004), 515 days of headache a month, premonitory symptoms before headache, no major medical conditions and not on preventive drugs for migraine or any other regular medications that could confound the study. We excluded patients with migraine aura to prevent confusion with premonitory symptoms, as both usually occur before headache. The study was approved by the UCSF Committee on Human Research and the Radiation Safety Committee. Written informed consent was obtained from all patients before study inclusion according to the Declaration of Helsinki.
Screening of patients
We initially screened 142 patients of which 25 satisfied the inclusion criteria and agreed to participate. The most common reasons for noninclusion were: headache 415 days a month (n = 41), migraine aura (n = 12), confounding medications (n = 25), patients unwilling due to radiation exposure (n = 8) and miscellaneous (n = 31; Supplementary Table 1) .
Infusion of nitroglycerin
The 25 patients fulfilling the inclusion criteria were invited for the first visit during which we infused intravenous nitroglycerin 0.5 mg/kg/min over 20 min to select patients who responded with premonitory symptoms before migraine headache. Patients were assessed before the nitroglycerin infusion and then at periodic intervals, initially every 5 min and then less frequently, every 10-15 min. Patients were asked about headache side, site, type and intensity, nausea, photophobia, phonophobia, movement sensitivity (not during scanning session), tiredness, neck stiffness, yawning, mood changes, micturition, thirst and cravings (Supplementary Table 2 ). Patients were assessed for all these parameters before the infusion and any significant change from baseline was considered positive.
Premonitory phase Clinical observations
The premonitory phase was defined as the period following when the nitroglycerin-induced non-specific headache phase had completely ceased and patients started to experience symptoms warning them of an impending headache. These symptoms had to be present on at least two enquiries. Symptoms were recorded as present or absent without grading. Blood pressure, oxygen saturation and pulse rate were recorded initially every 5 min and then less frequently. Of these 25 patients, 16 had delayed migraine headache. Of these 16, 11 patients had premonitory symptoms before migraine headache. These 11 patients were invited for PET scans at least 7 days after the first nitroglycerin infusion. All patients had been pain-free for at least 72 h before the PET scans. The procedure for nitroglycerin infusion and recording of symptoms was repeated as on the first occasion.
Functional imaging data collection
We performed PET scans with the GE Discovery VCT PET/CT system in 3D mode with septa retracted. All patients were instructed to keep their eyes closed during the scans. The patients were positioned in the PET scanner, and their head immobilized with standard immobilization straps and a low dose CT scan performed for attenuation correction. CT scans for attenuation correction were repeated when patients exited the scanner for relaxation between conditions with a maximum three exits per subject. An antecubital vein cannula was used to administer the tracer, $370 MBq of H 2 15 O, which was repeated before each scan. The activity was infused into patients over 20 s at a rate of 10 ml/min. The interval between scans was $10 min allowing an interscan interval of five half-lives of H 2 15 O (t 1/2 = 122 s). The PET data were acquired dynamically and summed for one 90-s frame beginning 5 s before the peak of the head curve.
Functional imaging conditions
Each patient had scans in three conditions: baseline, premonitory phase and migraine headache. We could not randomize the order of the scans since the premonitory and migraine headache phases were triggered by the nitroglycerin infusion sequentially. We planned to do three scans in each condition. The number of scans in the premonitory phase depended on how soon the migraine headache developed. Soon after the initiation of nitroglycerin, patients had a mild headache that lasted for 31 AE 12 min [mean AE (SD)]. Premonitory scans were performed after the nitroglycerin headache had completely subsided, premonitory symptoms were present and the migraine headache had not appeared. The time for the first premonitory scan after start of nitroglycerin infusion was 67 AE 34 min (range 40-142; see Fig. 1 for time line for scans and Table 1 ). Migraine scans were performed when the delayed headache was moderate or severe. The mean time for the first migraine headache scan after start of nitroglycerin infusion was 132 AE 69 min (range 82-270 min; Fig. 1 and Table 1 ). After the first scan during the premonitory and migraine headache phases, the subsequent scans were done at $10-min intervals.
Functional imaging scan distribution
Of 11 patients, eight could have at least one scan during the premonitory period when no pain was present. In the remaining three patients, either the nitroglycerin headache was followed by migraine headache without a pain-free interval or the premonitory stage was too short to allow the scans. Therefore, only these eight patients' scans were used for the final analysis. All the eight patients had three scans each during baseline. In the premonitory phase, three patients had two scans each, three patients had one scan each; one patient had three and one patient had four scans. In the migraine headache phase, five patients had three scans each, one patient had two, one patient had four and one patient had five scans.
Data preprocessing and statistical analysis
Images were reconstructed by 3D iterative reconstruction into 47 image planes (separation 3.27 mm) and into a 128 Â 128 image matrix (pixel size 2.1 Â 2.1 mm 2 ). SPM2 (www.fil.ion.ucl.ac.uk/spm) was used for data preprocessing and statistical analysis (Frackowiak and Friston, 1994) and paired t-tests were used to determine differences between conditions. Images were realigned with the first as reference and spatially normalized into MNI space. The normalized images were smoothed with a Gaussian filter of 8 mm full-width at half-maximum. Statistical parametric maps were derived with pre-specified contrasts as stated in the main text, comparing regional cerebral blood flow during states of interest. Correction for multiple comparisons was performed with false discovery rate (FDR) and P 5 0.05 was considered significant. As all our patients had either right-sided or predominantly right-sided headache, and none of them had purely or predominantly left-sided headache, the scans were not flipped.
To capture the temporal sequence of activation, we applied the following voxel wise contrasts: (i) first premonitory scans (early premonitory) of all patients against baseline scans of all patients; (ii) second premonitory scans (late premonitory) of all patients against baseline scans of all patients; (iii) all premonitory scans of all patients against baseline scans of all patients; and (iv) all migraine scans of all patients against baseline scans of all patients. The main outcome was activation pattern in the early premonitory scans which represented the earliest premonitory symptoms after exposure to trigger (nitroglycerin).
Results
Eight patients (five females; mean age 30 years, range 19-47 years, all right-handed) were included in the final analysis (Table 2) . During the scanning session, tiredness, neck stiffness and thirst were the three most common symptoms in the premonitory phase followed by frequent urination, photophobia, nausea, yawning and mood changes (Table 1) . Incidentally, all patients had either right-sided or bilateral, but predominantly right-sided migraine headache although this was not an inclusion criterion.
Brain areas activated Early premonitory
Brain areas activated in the early premonitory phase compared to baseline are listed in Table 3 and shown in Fig. 2 . Areas of note include the posterolateral hypothalamus, midbrain tegmental area and substantia nigra, periaqueductal grey, dorsal pons and various cortical areas including occipital, temporal and prefrontal cortex.
Late premonitory
Brain areas activated in the late premonitory phase compared to baseline are listed in Table 4 (Fig. 3) . Please note persistence of dorsal pontine activation but not of the hypothalamic and midbrain activations. Additionally, activations were seen in right pulvinar and left thalamic areas.
All premonitory
Brain areas activated in the premonitory phase (early and late together) compared to baseline are listed in Table 5 ( Fig. 3) . 
Migraine headache
Brain areas activated in the migraine headache phase compared to baseline are listed in Table 6 (Fig. 3) . It is notable that while dorsal pontine activation continues the postero-lateral hypothalamus and periaqueductal grey are not significantly activated. Table 7 shows the comparison of the activations in early and premonitory phases and migraine headache. Table 1 summarizes the total number of scans for each patient in each phase and how the scans were used to generate the contrasts.
For anatomical labelling of cortical and diencephalic areas, we initially converted the MNI coordinates into Talairach coordinates (non-linear) using http://www.brainmap.org/ale/. Then, we identified the nearest grey matter area for a given set of co-ordinates using the Talairach daemon software Using the above scans, the following contrasts were generated: 1. Early premonitory (main outcome). First premonitory scan of all patients (total 8) 4 all baseline scans of all patients (total 24), n = 8. 2. Late premonitory. Second premonitory scan of all patients (total 5) 4 all baseline scans of all patients (total 15), n = 5. 3. All premonitory scans of all patients (total 16) 4 all baseline scans of all patients (total 24), n = 8. 4. All migraine scans of all patients (total 26) 4 all baseline scans of all patients (total 24), n = 8. After the first scan in each phase i.e. baseline, premonitory and migraine headache, subsequent scans were done at $10-min intervals. VAS = visual-analogue scale. Mean AE SD for headache days/month; all fulfilling migraine headache = 4.6 AE 3.0; 95% confidence interval 2.0-7.1 OCP = oral contraceptive pill.
(http://www.talairach.org/client). For brainstem areas, we used the human atlas by DeArmond et al. (1976) to identify the areas. There was no significant difference between mean systolic and diastolic blood pressure measurements in baseline, premonitory and migraine headache phases (paired t-tests, P 4 0.05).
Discussion
We performed H 2 15 O PET cerebral blood flow scans as a surrogate for neuronal activity, referred to hereafter as activations (Frackowiak and Friston, 1994) , in nitroglycerin-induced migraine.
In the early premonitory phase as compared to baseline, we found activations in the right posterior and lateral regions of the hypothalamus (MNI co-ordinates = 6, À 6, À 12) and the adjacent right midbrain ventral tegmentum (Fig. 1) .These activations were more anterior to those observed in acute cluster headache (May et al., 1998) and distant from those previously reported in the headache phase of the attack (Denuelle et al., 2007) . The data offer insight into areas of the brain pivotal for the early phases of migraine suggesting structures that can be explored at the bench and neurotransmitter systems that may have therapeutic potential at the bedside. Hypothalamic and ventral tegmental involvement would explain yawning, possibly related to dopaminergic mechanisms (Argiolas and Melis, 1998) ; frequent urination and thirst, possibly relate to reduced vasopressin (Krowicki and Kapusta, 2011) and mood changes through hypothalamic connections with the limbic system (Sokolowski and Corbin, 2012) . The dopamine D 2 receptor antagonist domperidone is reported to be effective in preventing migraine headache when taken early in the attack, highlighting the importance of dopamine in the early stages (Waelkens, 1982 (Waelkens, , 1984 . The posterior/lateral hypothalamic region is the main location for hypocretin/orexin messenger RNA, which produces two related neuropeptides called hypocretin/orexin A and B (de Lecea et al., 1998) . Projections of the orexinergic system have been implicated in a variety of functions such as feeding, sleepwake cycle, neuroendocrine and autonomic functions (Ferguson and Samson, 2003; Sakurai, 2005) , all of which are relevant in migraine, most strikingly in the premonitory phase, although the role of orexin in trigeminal nociception can be either pro-or antinociceptive depending on the receptor activated (Bartsch et al., 2004) . Only one previous neuroimaging study has shown hypothalamic activation in migraine; this was anterior to what is now reported, and crucially seen during migraine headache (Denuelle et al., 2007) . These investigators scanned their patients within 4 h of onset of spontaneous migraine headache, which is earlier than in other previously reported studies in spontaneous migraine, with in 6 h (Weiller et al., 1995) or within 24 h (Afridi et al., 2005) . Hence, hypothalamic activation may occur in phases: right at the start of the attack during the premonitory phase, and later on during the headache. No previous neuroimaging study has investigated migraineurs just as the earliest signs of an attack are manifest-the premonitory phase.
The activations we found extended into the right midbrain, in the region of substantia nigra and the ventral tegmental area that gives rise to a dopaminergic projection to the hypothalamus through the medial forebrain bundle (You et al., 2001) . Rewarding stimulation of the lateral hypothalamus leads to release of dopamine in the ventral tegmental area and nucleus accumbens, suggesting these structures could be involved in craving, which is a characteristic premonitory symptom (You et al., 2001;  Giffin et al., 2003; Kelman, 2004) . We also found activations in the region of the periaqueductal grey and the red nucleus. The periaqueductal grey is an important region in pain control in general and migraine in particular. In a previous study, stereotactic electrodes placed in this area for chronic pain produced migrainelike headaches in patients without previous history of migraines (Raskin et al., 1987) . Dorsal pontine activation was seen in the region of the locus coeruleus. The locus coeruleus is a noradrenergic nucleus controlling the extracerebral and intracerebral vascular tone and has a modulatory effect on cortical excitability, thus possibly contributing to sensory dysmodulation leading to symptoms, such as photophobia and phonophobia (Akerman et al., 2011) . The hypothalamus (Charbit et al., 2009) , periaqueductal grey (Knight et al., 2002) and locus coeruleus (Lance et al., 1983) have been shown to influence physiology relevant to migraine. It can be speculated that activations in these areas in the premonitory phase could represent dysfunction that can potentially remove the top-down inhibitory effect on the trigeminocervical complex leading on to the initial neck stiffness/discomfort and eventually to the attack (Akerman et al., 2011) . The co-ordinates represent the maxima within a cluster. BA = Brodmann area; MNI = Montreal Neurological Institute
We found activations in predominantly right-sided frontal, and temporal cortex, and bilateral occipital cortex. The latter likely contributes to photophobia, which three of eight of our patients had. The cortical activation became less prominent as the headache appeared, in line with electrophysiological data showing restitution of habituation with headache (Schoenen et al., 2003) . Our study does not indicate whether the cortical or subcortical structures are involved first, although a previous study showed activation of the substantia nigra and red nucleus before occipital cortical activation in visually triggered migraine (Cao et al., 2002) . During the late premonitory phase, activations in the hypothalamus and midbrain regions were not seen and additionally activations were seen in the right pulvinar nucleus of thalamus and the left thalamus, contralateral to headache. Similarly, activation in the hypothalamic region was not seen when all premonitory scans were compared against baseline in our study, suggesting this activation is a very early phenomenon. Finally, in the migraine headache phase, activations were seen in the dorsal rostral pons and structures generally involved in pain processing as has been previously reported (Table 3) (Weiller et al., 1995; Bahra et al., 2001; Afridi et al., 2005a, b) .
It is noteworthy that the hypothalamic and brainstem activations in the premonitory phase were exclusively right-sided and patients developed purely or predominantly right-sided headache during the migraine headache phase. This suggests that ipsilateral involvement of these structures before the onset of headache may be involved in headache generation. In another study primarily looking at laterality of brainstem changes during nitroglycerin-triggered migraine headache it was shown that these changes occur ipsilateral to headache (Afridi et al., 2005) . The data are consistent with the anatomy of the first-order trigeminovascular neurons and the ipsilateral influence of these structures, particularly the periaqueductal grey and serotonergic raphe nuclei, on the trigeminocervical complex. However, it should be said that laterality was not an aim of our study and we did not choose patients with rightsided headache only during habitual attacks. The occurrence of pure or predominantly right-sided headache during the scanning The co-ordinates represent the maxima within a cluster. *After small volume correction with a sphere of radius 12 mm on co-ordinates x = 3, y = À36, z = À24. Uncorrected P-values 5 0.001 for all co-ordinates. BA = Brodmann area; MNI = Montreal Neurological Institute session was by chance. Furthermore, one needs to study left-sided headache also to fully establish the ipsilateral involvement of these structures in the premonitory phase. The activations we report are on the basis of increases in regional cerebral blood flow. We believe these changes are reflective of neuronal activity, as has been assumed in previous PET studies in migraine. We believe that there is no convincing literature supporting the view that the coupling between neuronal activity and haemodynamic response is abnormal in migraineurs globally. Rather previous literature indicates it may be normal in migraineurs, at least interictally (Schytz et al., 2010) . However, neurovascular coupling has not been systematically studied in the premonitory or migraine headache phases when triggered by nitroglycerin. All we can conclude is that the increased regional cerebral blood flow suggests a change in neuronal activity without making any assumptions about this is stimulatory or inhibitory to the connected neurons or the degree/intensity of the change.
Potential study limitations
Our study did not include a contemporaneous control group, so we cannot absolutely rule out that the observed activation changes during the premonitory and migraine headache phase relate to nitroglycerin administration rather than to migraine. However, we have previously studied the effect of nitroglycerin in PET using the same approach (Afridi et al., 2005b) . In addition to featureless headache soon after nitroglycerin and activations in the anterior cingulate cortex areas, we saw no changes in the regions here reported for the premonitory phase. It could be argued that exposing further controls to this method is unnecessary. Furthermore, the half-life of intravenous nitroglycerin is short, 55 min, as it is rapidly broken down into two inactive metabolites (Abrams, 1985) . Considering the mean time of 67 min to the first premonitory scan after the start of the nitroglycerin infusion, a vasodilator effect seems unlikely. A second potential limitation is the study was relatively small. The sample size is typical for PET in migraine (Weiller et al., 1995; Afridi et al., 2005a, b) , and given the biological plausibility, and the nature of the analysis, a positive result with smaller numbers is regarded by methodological experts as a very strong outcome (Friston, 2012) . Lastly, we screened 142 patients of which eight patients were included in the final analysis. This selection goes to generalizability. Our data certainly do not address patients with chronic migraine or those with confounding medical conditions and treatments. By definition we cannot address patients who do not have premonitory symptoms. The large exclusion rate reflects our design to have a pure sample, and the nature of social media and clinic patients who are generally more disabled and thus tend to reply to such advertisements. It seems likely our data reflect the more routine migraineur.
In conclusion, we provide neuroimaging evidence for the involvement of the hypothalamus and midbrain areas, periaqueductal grey and dorsal pons, in the earliest stages of migraine before the appearance of headache. For the first time the earliest part of the migraine attack has been imaged and there are clear changes without any pain. Hypothalamic involvement can explain many of the premonitory symptoms and may provide some insight into why migraine is commonly triggered by a change in homeostasis. The data offer targets for neurobiological studies at the bench and plausible neurotransmitter systems, such as dopaminergic and orexinergic targets, for bedside development of novel therapeutics.
